Clinical Trials Browser

Recruiting × INDUSTRY × Alpelisib × Clear all

NCT05948943 2026-02-13

EPIK-L1

Phase 2/3 Recruiting

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

NCT05563220 2026-01-06

ELEVATE

Phase 1/2 Recruiting

Breast Neoplasms

NCT05293470 2025-07-09

A Post Marketing Surveillance on Piqray in Korea

Breast Neoplasms